Correction to Allergan Story
September 12 2014 - 3:14PM
Dow Jones News
"Pershing Touts More Investor Support for Allergan Special
Meeting," published at 8:40 a.m. EDT, incorrectly said BMO Capital
Markets analyst David Maris has said that he thinks Valeant and
Pershing have a 50% to 60% chance of taking over Allergan. Rather,
BMO Capital Markets analyst Alex Arfaei said that. Mr. Maris,
meanwhile, said he believes there is less than a 50% chance of the
deal getting done.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024